Crescita Therapeutics, Inc.

{
  "main_header": {
    "sid": 1111331,
    "name": "Crescita Therapeutics, Inc.",
    "stock_name": "Crescita Therapeutics, Inc.",
    "full_name": "Crescita Therapeutics, Inc.",
    "name_url": "stocks-analysis/crescita-therapeutics-inc",
    "exchange": 30,
    "exchangecode": "TSE",
    "country_id": 1,
    "currency": "CAD",
    "cmp": "0.50",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.50",
    "mcapval": "9.21",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P/TSX 60",
    "isin": "CA2258471028",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "114 ",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/crescita-therapeutics-inc-1111331-30&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Crescita Therapeutics Experiences Valuation Shift Amid Strong Revenue Growth and Operational Efficiency",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/crescita-therapeutics-reports-5247-growth-in-net-sales-amid-valuation-upgrade-3768380",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CrescitaTherape_mojoScore_3768380.png",
        "date": "2025-12-24 15:46:12",
        "description": "Crescita Therapeutics, Inc. has recently experienced a change in its evaluation, reflecting a shift in valuation metrics. The company reported a 52.47% increase in net sales for the quarter ending June 2025 and improved cash flow management, despite facing challenges in stock valuation compared to historical averages."
      },
      {
        "title": "Crescita Therapeutics Reports Significant Sales Growth Amid Valuation Adjustments and Operational Efficiency Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/crescita-therapeutics-reports-5247-growth-in-net-sales-and-improved-cash-flow-3761510",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CrescitaTherape_mojoScore_3761510.png",
        "date": "2025-12-17 15:43:59",
        "description": "Crescita Therapeutics, Inc. has recently experienced a change in its evaluation, reflecting a shift in valuation metrics. The company reported a 52.47% increase in net sales for the quarter ending June 2025 and improved operational efficiency, despite being categorized as risky compared to historical valuations."
      },
      {
        "title": "Crescita Therapeutics Adjusts Valuation Amid Strong Sales Growth and Market Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/crescita-therapeutics-receives-stock-upgrade-amid-strong-sales-growth-and-profitability-improvements-3690008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CrescitaTherape_mojoScore_3690008.png",
        "date": "2025-11-11 16:26:05",
        "description": "Crescita Therapeutics, Inc. has recently experienced a change in its evaluation, highlighting its financial metrics and market position. The company reported a 52.47% increase in net sales for the quarter ending June 2025 and achieved its highest operating cash flow, indicating effective cash management amidst a complex financial landscape."
      }
    ],
    "total": 3,
    "sid": "1111331",
    "stock_news_url": "https://www.marketsmojo.com/news/crescita-therapeutics-inc-1111331"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Crescita Therapeutics Experiences Valuation Shift Amid Strong Revenue Growth and Operational Efficiency

2025-12-24 15:46:12

Crescita Therapeutics, Inc. has recently experienced a change in its evaluation, reflecting a shift in valuation metrics. The company reported a 52.47% increase in net sales for the quarter ending June 2025 and improved cash flow management, despite facing challenges in stock valuation compared to historical averages.

Read full news article

Crescita Therapeutics Reports Significant Sales Growth Amid Valuation Adjustments and Operational Efficiency Improvements

2025-12-17 15:43:59

Crescita Therapeutics, Inc. has recently experienced a change in its evaluation, reflecting a shift in valuation metrics. The company reported a 52.47% increase in net sales for the quarter ending June 2025 and improved operational efficiency, despite being categorized as risky compared to historical valuations.

Read full news article

Crescita Therapeutics Adjusts Valuation Amid Strong Sales Growth and Market Challenges

2025-11-11 16:26:05

Crescita Therapeutics, Inc. has recently experienced a change in its evaluation, highlighting its financial metrics and market position. The company reported a 52.47% increase in net sales for the quarter ending June 2025 and achieved its highest operating cash flow, indicating effective cash management amidst a complex financial landscape.

Read full news article

View All News